As of 2008, mankind is confronted by 346 generic infectious diseases, distributed in a seemingly haphazard fashion across 220 countries. An average of three new diseases are described every two years – and a new infecting organism is published every week ! Over 1,600 human pathogens have been reported, each with a specific set of phenotypic, genomic and susceptibility characteristics which must be confronted by diagnostic laboratories and clinicians. The pathogens are in turn confronted by 276 generic anti-infective agents and 67 vaccines – marketed under 10,493 proprietary names.
Table 1, below, lists the major infectious diseases and pathogens which have been reported since 1972. Many conditions on this list (ie, Lyme disease, Legionellosis, Cyclosporiasis) are in fact old diseases which were only “discovered” when technology permitted us to recognize their presence. This is also true of many “new” pathogens, which could only be discovered because of the advent of molecular biology and other sophisticated laboratory techniques.
Perhaps the most striking development in this regard has been the explosion in “new” viral respiratory pathogens: Acanthamoeba polyphaga mimivirus, Bat reovirus, Human Bocavirus, Human Coronavirus HKU1, Human Coronavirus NL63, Human CoV 229E, Human CoV OC43, HRV-A, HRV-B, HRV-C, Human metapneumovirus, Karolinska Institutet virus, New Haven Coronavirus, Small Anellovirus, Tioman virus, Torque tenovirus and Washington University polyomavirus.
Another trend in this regard has been the discovery of infectious etiologies for “non-infectious” diseases: Kaposi sarcoma, peptic ulcer, cervical cancer, Whipple’s disease, to name a few.
Paradoxically, while technology has allowed us to discover and treat new diseases and pathogens, it has also contributed to the evolution of the diseases themselves. Broad-spectrum antibiotics, immunosuppressive drugs, prosthetic and transplantation surgery have each created a niche for opportunistic pathogens. Indeed, each breakthrough in the prolongation of human life and ability to treat heretofore fatal diseases is inevitably followed by an interesting list of Infectious Diseases challenges. On a broader scale, the scope of Infectious Diseases will be increasingly challenged by societal pressures related to overpopulation, air travel, global warming, conflict, famine, deforestation and bioterrorism.
As of 2008, GIDEON is the only Infectious Diseases program which follows the status of new diseases, outbreaks, antimicrobial agents, vaccines and pathogens. An ongoing summary of GIDEON content is available here.
Table 1: Major Infectious Diseases reported since 1972
|1975||Parvovirus B19||Fifth disease|
|1980||T-lymphotrophic virus||T-cell leukemia|
|1981||Toxigenic S. aureus||Toxic shock syndrome|
|1982||E. coli O157:H7||Hemorrhagic colitis, HUS|
|1982||HTLV-II||Hairy cell leukemia|
|1982||Borrelia burgdorferi||Lyme disease|
|1983||Helicobacter pylori||Peptic ulcer disease|
|1988||Human Herpes 6||Roseola infantum|
|1988||Hepatitis E virus||Hepatitis E|
|1989||Hepatitis C virus||Hepatitis C|
|1989||Guanarito virus||Venezuelan hemorrhagic fever|
|1992||Bartonella henselae||Cat scratch disease|
|1993||Sin nombre virus||Hantavirus pulmonary syndrome|
|1994||Sabia virus||Brazilian hemorrhagic fever|
|1995||Human herpesvirus 8||Kaposi sarcoma|
|1999||Nipah virus||Nipah virus disease|